Research Study

MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation.

📅 2023 🔗 DOI: 10.3389/fendo.2023.1120533
Citation
Zheng Y., Wei Z., Wang T. (2023). MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation.. Front Endocrinol (Lausanne). DOI: 10.3389/fendo.2023.1120533
View Full Study →

Abstract

Abstract not available. See citation for source.

Related Substances

Mots C
Disclaimer: This research summary is for educational purposes only. Always consult with a healthcare professional before making decisions based on scientific research.